Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat

Jeffrey R. Rowland, Pamela E. Binkerd, Andrew G Hendrickx

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Correlations between oral and intravenous (i.v.) doses of phenytoin, maternal plasma levels, and subsequent developmental toxicity were examined in the Sprague-Dawley rat. Oral administration of 150 to 1500 mg/kg and i.v. administration of 25 to 100 mg/kg phenytoin from gestational days (GD) 8 to 17 resulted in a dose-dependent increase in maternal death and toxicity [impaired motor function, decreased maternal weight gain (oral dose only)], embryolethality, and intrauterine growth retardation, in addition to significant increases in craniofacial (1125 mg/kg oral; 75 mg/kg i.v.) and urogenital (1125 mg/kg oral) malformations. Pharmacokinetic sampling in oral and i.v. groups on GD 8-9 and 16-17 revealed significant increases in maternal drug exposure over the treatment period, as evidenced by 2- to 3-fold increases in total plasma phenytoin (bound + free) half-life, area under the concentration curve, peak concentration (oral dose only), and decreases in clearance. These findings emphasize the importance of pharmacokinetics in the evaluation of phenytoin-induced developmental toxicity.

Original languageEnglish (US)
Pages (from-to)191-202
Number of pages12
JournalReproductive Toxicology
Volume4
Issue number3
DOIs
StatePublished - 1990

Fingerprint

Pharmacokinetics
Phenytoin
Toxicity
Rats
Mothers
Plasmas
Maternal Exposure
Maternal Death
Fetal Growth Retardation
Intravenous Administration
Weight Gain
Area Under Curve
Oral Administration
Sprague Dawley Rats
Half-Life
Sampling
Pharmaceutical Preparations
Therapeutics

Keywords

  • developmental toxicity
  • intravenous
  • oral
  • pharmacokinetics
  • Phenytoin
  • plasma
  • rat
  • Sprague-Dawley

ASJC Scopus subject areas

  • Toxicology

Cite this

Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat. / Rowland, Jeffrey R.; Binkerd, Pamela E.; Hendrickx, Andrew G.

In: Reproductive Toxicology, Vol. 4, No. 3, 1990, p. 191-202.

Research output: Contribution to journalArticle

Rowland, Jeffrey R. ; Binkerd, Pamela E. ; Hendrickx, Andrew G. / Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat. In: Reproductive Toxicology. 1990 ; Vol. 4, No. 3. pp. 191-202.
@article{b3e093abbe0546c8bf917f0b6b81321b,
title = "Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat",
abstract = "Correlations between oral and intravenous (i.v.) doses of phenytoin, maternal plasma levels, and subsequent developmental toxicity were examined in the Sprague-Dawley rat. Oral administration of 150 to 1500 mg/kg and i.v. administration of 25 to 100 mg/kg phenytoin from gestational days (GD) 8 to 17 resulted in a dose-dependent increase in maternal death and toxicity [impaired motor function, decreased maternal weight gain (oral dose only)], embryolethality, and intrauterine growth retardation, in addition to significant increases in craniofacial (1125 mg/kg oral; 75 mg/kg i.v.) and urogenital (1125 mg/kg oral) malformations. Pharmacokinetic sampling in oral and i.v. groups on GD 8-9 and 16-17 revealed significant increases in maternal drug exposure over the treatment period, as evidenced by 2- to 3-fold increases in total plasma phenytoin (bound + free) half-life, area under the concentration curve, peak concentration (oral dose only), and decreases in clearance. These findings emphasize the importance of pharmacokinetics in the evaluation of phenytoin-induced developmental toxicity.",
keywords = "developmental toxicity, intravenous, oral, pharmacokinetics, Phenytoin, plasma, rat, Sprague-Dawley",
author = "Rowland, {Jeffrey R.} and Binkerd, {Pamela E.} and Hendrickx, {Andrew G}",
year = "1990",
doi = "10.1016/0890-6238(90)90058-4",
language = "English (US)",
volume = "4",
pages = "191--202",
journal = "Reproductigve Toxicoloy",
issn = "0890-6238",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat

AU - Rowland, Jeffrey R.

AU - Binkerd, Pamela E.

AU - Hendrickx, Andrew G

PY - 1990

Y1 - 1990

N2 - Correlations between oral and intravenous (i.v.) doses of phenytoin, maternal plasma levels, and subsequent developmental toxicity were examined in the Sprague-Dawley rat. Oral administration of 150 to 1500 mg/kg and i.v. administration of 25 to 100 mg/kg phenytoin from gestational days (GD) 8 to 17 resulted in a dose-dependent increase in maternal death and toxicity [impaired motor function, decreased maternal weight gain (oral dose only)], embryolethality, and intrauterine growth retardation, in addition to significant increases in craniofacial (1125 mg/kg oral; 75 mg/kg i.v.) and urogenital (1125 mg/kg oral) malformations. Pharmacokinetic sampling in oral and i.v. groups on GD 8-9 and 16-17 revealed significant increases in maternal drug exposure over the treatment period, as evidenced by 2- to 3-fold increases in total plasma phenytoin (bound + free) half-life, area under the concentration curve, peak concentration (oral dose only), and decreases in clearance. These findings emphasize the importance of pharmacokinetics in the evaluation of phenytoin-induced developmental toxicity.

AB - Correlations between oral and intravenous (i.v.) doses of phenytoin, maternal plasma levels, and subsequent developmental toxicity were examined in the Sprague-Dawley rat. Oral administration of 150 to 1500 mg/kg and i.v. administration of 25 to 100 mg/kg phenytoin from gestational days (GD) 8 to 17 resulted in a dose-dependent increase in maternal death and toxicity [impaired motor function, decreased maternal weight gain (oral dose only)], embryolethality, and intrauterine growth retardation, in addition to significant increases in craniofacial (1125 mg/kg oral; 75 mg/kg i.v.) and urogenital (1125 mg/kg oral) malformations. Pharmacokinetic sampling in oral and i.v. groups on GD 8-9 and 16-17 revealed significant increases in maternal drug exposure over the treatment period, as evidenced by 2- to 3-fold increases in total plasma phenytoin (bound + free) half-life, area under the concentration curve, peak concentration (oral dose only), and decreases in clearance. These findings emphasize the importance of pharmacokinetics in the evaluation of phenytoin-induced developmental toxicity.

KW - developmental toxicity

KW - intravenous

KW - oral

KW - pharmacokinetics

KW - Phenytoin

KW - plasma

KW - rat

KW - Sprague-Dawley

UR - http://www.scopus.com/inward/record.url?scp=0025525362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025525362&partnerID=8YFLogxK

U2 - 10.1016/0890-6238(90)90058-4

DO - 10.1016/0890-6238(90)90058-4

M3 - Article

C2 - 2136036

AN - SCOPUS:0025525362

VL - 4

SP - 191

EP - 202

JO - Reproductigve Toxicoloy

JF - Reproductigve Toxicoloy

SN - 0890-6238

IS - 3

ER -